These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 23387271)
1. [Bioinformatic analysis of potential post-translational modification sites of the human O6-methylguanine-DNA methyltransferase (MGMT) protein]. Iatsyshyna AP; Nidoieva ZM; Pidpala OV; Lukash LL Ukr Biokhim Zh (1999); 2012; 84(6):74-85. PubMed ID: 23387271 [TBL] [Abstract][Full Text] [Related]
2. Formation and degradation of nitrogen mustard-induced MGMT-DNA crosslinking in 16HBE cells. Cheng J; Ye F; Dan G; Zhao Y; Zhao J; Zou Z Toxicology; 2017 Aug; 389():67-73. PubMed ID: 28720507 [TBL] [Abstract][Full Text] [Related]
3. A distinct region of the MGMT CpG island critical for transcriptional regulation is preferentially methylated in glioblastoma cells and xenografts. Malley DS; Hamoudi RA; Kocialkowski S; Pearson DM; Collins VP; Ichimura K Acta Neuropathol; 2011 May; 121(5):651-61. PubMed ID: 21287394 [TBL] [Abstract][Full Text] [Related]
4. Anatomic localization of O6-methylguanine DNA methyltransferase (MGMT) promoter methylated and unmethylated tumors: a radiographic study in 358 de novo human glioblastomas. Ellingson BM; Cloughesy TF; Pope WB; Zaw TM; Phillips H; Lalezari S; Nghiemphu PL; Ibrahim H; Naeini KM; Harris RJ; Lai A Neuroimage; 2012 Jan; 59(2):908-16. PubMed ID: 22001163 [TBL] [Abstract][Full Text] [Related]
6. Development of a new application of the comet assay to assess levels of O6-methylguanine in genomic DNA (CoMeth). Ramos AA; Pedro DF; Lima CF; Collins AR; Pereira-Wilson C Free Radic Biol Med; 2013 Jul; 60():41-8. PubMed ID: 23391575 [TBL] [Abstract][Full Text] [Related]
7. Role of histone modifications and DNA methylation in the regulation of O6-methylguanine-DNA methyltransferase gene expression in human stomach cancer cells. Meng CF; Zhu XJ; Peng G; Dai DQ Cancer Invest; 2010 May; 28(4):331-9. PubMed ID: 19857042 [TBL] [Abstract][Full Text] [Related]
8. Relevance of MSP assay for the detection of MGMT promoter hypermethylation in glioblastomas. Yachi K; Watanabe T; Ohta T; Fukushima T; Yoshino A; Ogino A; Katayama Y; Nagase H Int J Oncol; 2008 Sep; 33(3):469-75. PubMed ID: 18695875 [TBL] [Abstract][Full Text] [Related]
9. MGMT methylation in diffuse large B-cell lymphoma: validation of quantitative methylation-specific PCR and comparison with MGMT protein expression. Uccella S; Cerutti R; Placidi C; Marchet S; Carnevali I; Bernasconi B; Proserpio I; Pinotti G; Tibiletti MG; Furlan D; Capella C J Clin Pathol; 2009 Aug; 62(8):715-23. PubMed ID: 19638543 [TBL] [Abstract][Full Text] [Related]
10. An analysis of image texture, tumor location, and MGMT promoter methylation in glioblastoma using magnetic resonance imaging. Drabycz S; Roldán G; de Robles P; Adler D; McIntyre JB; Magliocco AM; Cairncross JG; Mitchell JR Neuroimage; 2010 Jan; 49(2):1398-405. PubMed ID: 19796694 [TBL] [Abstract][Full Text] [Related]
11. Methylation of MGMT in malignant pleural mesothelioma occurs in a subset of patients and is associated with the T allele of the rs16906252 MGMT promoter SNP. Kristensen LS; Nielsen HM; Hager H; Hansen LL Lung Cancer; 2011 Feb; 71(2):130-6. PubMed ID: 20627446 [TBL] [Abstract][Full Text] [Related]
12. Association between response to primary treatments and MGMT status in glioblastoma. Franceschi E; Tosoni A; Pozzati E; Brandes AA Expert Rev Anticancer Ther; 2008 Nov; 8(11):1781-6. PubMed ID: 18983238 [TBL] [Abstract][Full Text] [Related]
13. Confounding factors in diagnostics of MGMT promoter methylation status in glioblastomas in stereotactic biopsies. Weise LM; Harter PN; Eibach S; Braczynski AK; Dunst M; Rieger J; Bähr O; Hattingen E; Steinbach JP; Plate KH; Seifert V; Mittelbronn M Stereotact Funct Neurosurg; 2014; 92(3):129-39. PubMed ID: 24776650 [TBL] [Abstract][Full Text] [Related]
14. Methylation status of the MGMT gene promoter fails to predict the clinical outcome of glioblastoma patients treated with ACNU plus cisplatin. Park CK; Park SH; Lee SH; Kim CY; Kim DW; Paek SH; Kim DG; Heo DS; Kim IH; Jung HW Neuropathology; 2009 Aug; 29(4):443-9. PubMed ID: 19170894 [TBL] [Abstract][Full Text] [Related]
15. Genetic association and functional studies of major polymorphic variants of MGMT. Bugni JM; Han J; Tsai MS; Hunter DJ; Samson LD DNA Repair (Amst); 2007 Aug; 6(8):1116-26. PubMed ID: 17569599 [TBL] [Abstract][Full Text] [Related]
16. Human variants of O6-alkylguanine-DNA alkyltransferase. Pegg AE; Fang Q; Loktionova NA DNA Repair (Amst); 2007 Aug; 6(8):1071-8. PubMed ID: 17482892 [TBL] [Abstract][Full Text] [Related]
17. Correlation between promoter hypermethylation of GSTP1 and response to chemotherapy in diffuse large B cell lymphoma. Nakamichi I; Tomita Y; Zhang B; Sugiyama H; Kanakura Y; Fukuhara S; Hino M; Kanamaru A; Ogawa H; Aozasa K Ann Hematol; 2007 Aug; 86(8):557-64. PubMed ID: 17508213 [TBL] [Abstract][Full Text] [Related]
19. MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents. Kaina B; Christmann M; Naumann S; Roos WP DNA Repair (Amst); 2007 Aug; 6(8):1079-99. PubMed ID: 17485253 [TBL] [Abstract][Full Text] [Related]
20. Association of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation with p53 mutation occurrence in non-small cell lung cancer with different histology, gender, and smoking status. Wu JY; Wang J; Lai JC; Cheng YW; Yeh KT; Wu TC; Chen CY; Lee H Ann Surg Oncol; 2008 Nov; 15(11):3272-7. PubMed ID: 18712569 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]